Irène Vonfeld, Antoine Leclerc, Luca Zilberstein, Maïalen Pérot, Sandra Avril, Benjamin Lamglait, Dorothée Ordonneau, Milan Thorel, La Ménagerie, Philippe Hennet, Lucie Brisson
{"title":"在两头大独角犀牛体内输注丁吗啡诺、氯胺酮和愈创木酚维持全静脉麻醉","authors":"Irène Vonfeld, Antoine Leclerc, Luca Zilberstein, Maïalen Pérot, Sandra Avril, Benjamin Lamglait, Dorothée Ordonneau, Milan Thorel, La Ménagerie, Philippe Hennet, Lucie Brisson","doi":"10.1002/vrc2.920","DOIUrl":null,"url":null,"abstract":"This report describes the use of an ultrapotent, opioid‐free anaesthesia with an infusion of butorphanol, ketamine and guaifenesin in two captive adult male greater one‐horned rhinoceros (<jats:italic>Rhinoceros unicornis</jats:italic>). Animals were premedicated intramuscularly with azaperone (0.05 mg/kg), butorphanol tartrate (0.05 and 0.02 mg/kg, respectively) and an α2‐agonist (detomidine 0.02 mg/kg and medetomidine 0.01 mg/kg, respectively). Once sternolaterally recumbent, rhinoceros were induced with intravenous ketamine (0.02 and 0.05 mg/kg, respectively) and midazolam (7.0 and 8.0 μg/kg, respectively). Intravenous infusions of guaifenesin (15.1 and 25 mg/kg/h, respectively) and of ketamine (22.5 and 29.1 μg/kg/h, respectively) and butorphanol (15.7 and 20.3 μg/kg/h, respectively), allowed stable anaesthesia maintenance for dental procedures to take place. Supplemental boluses of ketamine and α2‐agonist were required during noxious stimulation in both cases. Animals were reversed with intramuscular atipamezole (0.07–0.08 mg/kg) and naltrexone (0.06–0.08 mg/kg), with or without flumazenil (0.10 μg/kg), allowing smooth and quick recovery.","PeriodicalId":23496,"journal":{"name":"Veterinary Record Case Reports","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Total intravenous anaesthesia maintenance with an infusion of butorphanol, ketamine and guaifenesin in two greater one‐horned rhinoceros (Rhinoceros unicornis)\",\"authors\":\"Irène Vonfeld, Antoine Leclerc, Luca Zilberstein, Maïalen Pérot, Sandra Avril, Benjamin Lamglait, Dorothée Ordonneau, Milan Thorel, La Ménagerie, Philippe Hennet, Lucie Brisson\",\"doi\":\"10.1002/vrc2.920\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This report describes the use of an ultrapotent, opioid‐free anaesthesia with an infusion of butorphanol, ketamine and guaifenesin in two captive adult male greater one‐horned rhinoceros (<jats:italic>Rhinoceros unicornis</jats:italic>). Animals were premedicated intramuscularly with azaperone (0.05 mg/kg), butorphanol tartrate (0.05 and 0.02 mg/kg, respectively) and an α2‐agonist (detomidine 0.02 mg/kg and medetomidine 0.01 mg/kg, respectively). Once sternolaterally recumbent, rhinoceros were induced with intravenous ketamine (0.02 and 0.05 mg/kg, respectively) and midazolam (7.0 and 8.0 μg/kg, respectively). Intravenous infusions of guaifenesin (15.1 and 25 mg/kg/h, respectively) and of ketamine (22.5 and 29.1 μg/kg/h, respectively) and butorphanol (15.7 and 20.3 μg/kg/h, respectively), allowed stable anaesthesia maintenance for dental procedures to take place. Supplemental boluses of ketamine and α2‐agonist were required during noxious stimulation in both cases. Animals were reversed with intramuscular atipamezole (0.07–0.08 mg/kg) and naltrexone (0.06–0.08 mg/kg), with or without flumazenil (0.10 μg/kg), allowing smooth and quick recovery.\",\"PeriodicalId\":23496,\"journal\":{\"name\":\"Veterinary Record Case Reports\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Veterinary Record Case Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/vrc2.920\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"VETERINARY SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary Record Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/vrc2.920","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
Total intravenous anaesthesia maintenance with an infusion of butorphanol, ketamine and guaifenesin in two greater one‐horned rhinoceros (Rhinoceros unicornis)
This report describes the use of an ultrapotent, opioid‐free anaesthesia with an infusion of butorphanol, ketamine and guaifenesin in two captive adult male greater one‐horned rhinoceros (Rhinoceros unicornis). Animals were premedicated intramuscularly with azaperone (0.05 mg/kg), butorphanol tartrate (0.05 and 0.02 mg/kg, respectively) and an α2‐agonist (detomidine 0.02 mg/kg and medetomidine 0.01 mg/kg, respectively). Once sternolaterally recumbent, rhinoceros were induced with intravenous ketamine (0.02 and 0.05 mg/kg, respectively) and midazolam (7.0 and 8.0 μg/kg, respectively). Intravenous infusions of guaifenesin (15.1 and 25 mg/kg/h, respectively) and of ketamine (22.5 and 29.1 μg/kg/h, respectively) and butorphanol (15.7 and 20.3 μg/kg/h, respectively), allowed stable anaesthesia maintenance for dental procedures to take place. Supplemental boluses of ketamine and α2‐agonist were required during noxious stimulation in both cases. Animals were reversed with intramuscular atipamezole (0.07–0.08 mg/kg) and naltrexone (0.06–0.08 mg/kg), with or without flumazenil (0.10 μg/kg), allowing smooth and quick recovery.
期刊介绍:
Vet Record Case Reports is an online resource that publishes articles in all fields of veterinary medicine and surgery so that veterinary professionals, researchers and others can easily find important information on both common and rare conditions. Articles may be about a single animal, herd, flock or other group of animals managed together. Common cases that present a diagnostic, ethical or management challenge, or that highlight aspects of mechanisms of injury, pharmacology or histopathology are deemed of particular educational value. All articles are peer reviewed and copy edited before publication.